Literature DB >> 12884158

Relationships between patient- and institution-specific variables and decreased antimicrobial susceptibility of Gram-negative pathogens.

Sujata M Bhavnani1, Jeffrey P Hammel, Alan Forrest, Ronald N Jones, Paul G Ambrose.   

Abstract

The identification of patients infected with antibiotic-resistant strains of bacteria for inclusion in clinical trials remains a serious challenge for the future development of agents for use against such infections. To identify patient- and institution-specific factors predictive of reduced susceptibility of Enterobacter species, Pseudomonas aeruginosa, and Klebsiella pneumoniae to cefepime, ciprofloxacin, and piperacillin-tazobactam, 5 years (1997-2001) of North American surveillance data were analyzed. The relationship between minimum inhibitory concentration (MIC) values for each organism-agent pair and patient- and institution-specific variables was analyzed using multivariable general linear modeling. The variables most commonly associated with decreases in susceptibility were duration of hospital stay before pathogen isolation, hospital size, primary diagnosis, and medical service. Combinations of these variables were associated with increases in observed MIC90 values of as much as 16-32-fold. Our findings demonstrate a relationship between MIC and certain patient- and institution-specific variables. Such data should be considered in the design of clinical trials directed at the study of resistant pathogens.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12884158     DOI: 10.1086/375817

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  6 in total

1.  Comparison of censored regression and standard regression analyses for modeling relationships between antimicrobial susceptibility and patient- and institution-specific variables.

Authors:  Jeffrey P Hammel; Sujata M Bhavnani; Ronald N Jones; Alan Forrest; Paul G Ambrose
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

2.  Relationship between Fosfomycin Exposure and Amplification of Escherichia coli Subpopulations with Reduced Susceptibility in a Hollow-Fiber Infection Model.

Authors:  Brian VanScoy; Jennifer McCauley; Sujata M Bhavnani; Evelyn J Ellis-Grosse; Paul G Ambrose
Journal:  Antimicrob Agents Chemother       Date:  2016-08-22       Impact factor: 5.191

3.  Relationship between ceftolozane-tazobactam exposure and selection for Pseudomonas aeruginosa resistance in a hollow-fiber infection model.

Authors:  Brian D VanScoy; Rodrigo E Mendes; Mariana Castanheira; Jennifer McCauley; Sujata M Bhavnani; Ronald N Jones; Lawrence V Friedrich; Judith N Steenbergen; Paul G Ambrose
Journal:  Antimicrob Agents Chemother       Date:  2014-07-28       Impact factor: 5.191

4.  Predictors of mortality in patients with bloodstream infection due to ceftazidime-resistant Klebsiella pneumoniae.

Authors:  Deverick J Anderson; John J Engemann; Lizzie J Harrell; Yehuda Carmeli; L Barth Reller; Keith S Kaye
Journal:  Antimicrob Agents Chemother       Date:  2006-05       Impact factor: 5.191

5.  Replacement of broad-spectrum cephalosporins by piperacillin-tazobactam: impact on sustained high rates of bacterial resistance.

Authors:  Carlos Bantar; Eduardo Vesco; Claudia Heft; Francisco Salamone; Marcelo Krayeski; Hernán Gomez; María Alicia Coassolo; Alejandro Fiorillo; Diego Franco; Carina Arango; Fernando Duret; María Eugenia Oliva
Journal:  Antimicrob Agents Chemother       Date:  2004-02       Impact factor: 5.191

6.  On being the right size: the impact of population size and stochastic effects on the evolution of drug resistance in hospitals and the community.

Authors:  Roger D Kouyos; Pia Abel Zur Wiesch; Sebastian Bonhoeffer
Journal:  PLoS Pathog       Date:  2011-04-14       Impact factor: 6.823

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.